BeOne Medicines Ltd (ONC)

• Market cap: $32.7B
• 1 day: -0.48%
• 5 days: -1.6%
• 1 month: -4.73%
• 3 months: -14.82%
• 6 months: -5.77%
• Year to date: -5.52%
• 1 year: 14.95%
• 5 years: -12.93%
• 10 years: 981.56%
• Sector: Healthcare
• Industry: Biotechnology

About: BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.

Employees: 12,000